The next coronavirus: how a biotech boom is boosting Asian defences

When Singapore biotech company Celligenics was established three years ago, its founders decided that it should be rooted in Asia so it could solve Asian problems.The company, which specialises in small cell regeneration, aims to ease the problems faced by the region’s ageing population, such as chronic conditions arising from diabetes.“Diabetes is a growing problem in Asia and we are looking at conditions that diabetic patients suffer from, like non-healing wounds,” said Kurt Wee, the chief…

from South China Morning Post https://ift.tt/2ODwLmL
Dewey Sim When Singapore biotech company Celligenics was established three years ago, its founders decided that it should be rooted in Asia so it could solve Asian problems.The company, which specialises in small cell regeneration, aims to ease the problems faced by the region’s ageing population, such as chronic conditions arising from diabetes.“Diabetes is a growing problem in Asia and we are looking at conditions that diabetic patients suffer from, like non-healing wounds,” said Kurt Wee, the chief… https://ift.tt/eA8V8J February 08, 2020 at 01:45AM